New York State Common Retirement Fund
PRME icon

New York State Common Retirement Fund’s Prime Medicine PRME Stock Holding History

New York State Common Retirement Fund’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.4K Hold
8,434
– – ﹤0.01% 2952
2025
Q4 		$29.3K Hold
8,434
– – ﹤0.01% 3028
2025
Q3 		$46.7K Hold
8,434
– – ﹤0.01% 2971
2025
Q2 		$20.8K Hold
8,434
– – ﹤0.01% 3111
2025
Q1 		$16.8K Hold
8,434
– – ﹤0.01% 3005
2024
Q4 		$24.6K Hold
8,434
– – ﹤0.01% 3008
2024
Q3 		$32.6K Hold
8,434
– – ﹤0.01% 2972
2024
Q2 		$43.4K Buy
8,434
+11
+0.1% +$67 ﹤0.01% 3124
2024
Q1 		$59K Sell
8,423
-17
-0.2% -$129 ﹤0.01% 2934
2023
Q4 		$74.8K Sell
8,440
-7,876
-48% -$60.7K ﹤0.01% 2853
2023
Q3 		$156K Buy
16,316
+332
+2% +$4.31K ﹤0.01% 2531
2023
Q2 		$234K Buy
15,984
+8,191
+105% +$114K ﹤0.01% 2424
2023
Q1 		$95.9K Buy
7,793
+2,793
+56% +$45.5K ﹤0.01% 2827
2022
Q4 		$92.9K Buy
+5,000
New +$90.3K ﹤0.01% 2979

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

New York State Common Retirement Fund's PRME Position: Q1 2026 in Review

New York State Common Retirement Fund held its Prime Medicine (PRME) position steady in Q1 2026 at 8,434 shares worth $29.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2952.

New York State Common Retirement Fund first reported a position in PRME in Q4 2022 and has held it in 14 quarters since. The position peaked at $234K in Q2 2023. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • New York State Common Retirement Fund held 8,434 shares of Prime Medicine worth $29.4K as of Q1 2026.
  • New York State Common Retirement Fund left its Prime Medicine share count unchanged in Q1 2026.
  • Prime Medicine made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #2952 holding.
  • New York State Common Retirement Fund first reported a position in Prime Medicine in Q4 2022 and has held it in 14 quarters since.
  • New York State Common Retirement Fund's Prime Medicine position peaked at $234K in Q2 2023.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.